(Q43981729)

28 November 2017

Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based study (English)

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

6 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

6 November 2022

2

B Glimelius

1 reference

28 November 2017

G. Enblad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714293

6 November 2022

C. Sundström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714293

6 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1714293

6 November 2022

publication date

1 April 1991

1 reference

full work available at URL

28 November 2017

http://annonc.oxfordjournals.org/cgi/content/abstract/2/4/297

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714293

https://api.elsevier.com/content/article/PII:S0923753420303367?httpAccept=text/xml

6 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

https://api.elsevier.com/content/article/PII:S0923753420303367?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

http://academic.oup.com/annonc/article-pdf/2/4/297/395851/2-4-297.pdf

6 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

6 November 2022

1 reference

28 November 2017

2

1 reference

28 November 2017

4

1 reference

28 November 2017

297-302

1 reference

Prognostic factors in Hodgkin's disease with special reference to age

28 November 2017

3

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index

6 November 2022

4

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

A multivariate analysis of prognostic factors in early stage Hodgkin's disease

6 November 2022

5

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

The prognostic significance of age in Hodgkin's disease: examination of 1500 patients (BNLI report no. 23)

6 November 2022

6

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

An analysis of prognostic factors in early stage Hodgkin's disease

6 November 2022

7

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Hodgkin's disease in the elderly

6 November 2022

9

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Hodgkin's disease in patients over sixty years old

6 November 2022

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis

6 November 2022

12

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis

6 November 2022

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Hodgkin's disease in the elderly. A series of 30 patients aged older than 70 years

6 November 2022

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Analysis of grade 1 Hodgkin's disease (Report no 6)

6 November 2022

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease

6 November 2022

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

6 November 2022

24

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

A computer program package for relative survival analysis

6 November 2022

25

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

Maximum utilization of the life table method in analyzing survival

6 November 2022

26

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057939

6 November 2022

Identifiers

1 reference

release_yv32lvsblbed3jh5cmkfxp4ziy

28 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yv32lvsblbed3jh5cmkfxp4ziy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference